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Abstract
Background: Mice with peroxisome deficiency in neural cells (Nestin-Pex5−/−) develop a neurodegenerative
phenotype leading to motor and cognitive disabilities and early death. Major pathologies at the end stage of
disease include severe demyelination, axonal degeneration and neuroinflammation. We now investigated the onset
and progression of these pathological processes, and their potential interrelationship. In addition, the putative role
of oxidative stress, the impact of plasmalogen depletion on the neurodegenerative phenotype, and the
consequences of peroxisome elimination in the postnatal period were studied.
Methods: Immunohistochemistry in association with gene expression analysis was performed on Nestin-Pex5−/−
mice to document demyelination, axonal damage and neuroinflammation. Also Gnpat−/− mice, with selective
plasmalogen deficiency and CMV-Tx-Pex5−/− mice, with tamoxifen induced generalized loss of peroxisomes were
analysed.
Results: Activation of the innate immune system is a very early event in the pathological process in Nestin-Pex5−/−
mice which evolves in chronic neuroinflammation. The complement factor C1q, one of the earliest up regulated
transcripts, was expressed on neurons and oligodendrocytes but not on microglia. Transcripts of other pro- and
anti-inflammatory genes and markers of phagocytotic activity were already significantly induced before detecting
pathologies with immunofluorescent staining. Demyelination, macrophage activity and axonal loss co-occurred
throughout the brain. As in patients with mild peroxisome biogenesis disorders who develop regressive changes,
demyelination in cerebellum and brain stem preceded major myelin loss in corpus callosum of both Nestin-Pex5−/−
and CMV-Tx-Pex5−/− mice. These lesions were not accompanied by generalized oxidative stress throughout the
brain. Although Gnpat−/− mice displayed dysmyelination and Purkinje cell axon damage in cerebellum, confirming
previous observations, no signs of inflammation or demyelination aggravating with age were observed.
Conclusions: Peroxisome inactivity triggers a fast neuroinflammatory reaction, which is not solely due to the
depletion of plasmalogens. In association with myelin abnormalities this causes axon damage and loss.
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Background
Patients with peroxisomal dysfunction present with severe
and diverse neurological anomalies, including neuronal
migration defects, dysmyelination and inflammatory de-
myelination and axon damage, proving that these orga-
nelles are indispensible for the normal development and
maintenance of the central nervous system (CNS) [1-3].
According to the genetic causes these diseases can be cate-
gorized in peroxisome biogenesis defects (PBDs) and in
single enzyme or transporter deficiencies. The PBDs are
due to a mutation in a PEX gene, encoding a peroxin
involved in the assembly of the organelles. The enzyme/
transporter defects mostly involve 1) the peroxisomal α-
oxidation pathway, necessary for the breakdown of phyta-
nic acid and long chain 2-hydroxy fatty acids, 2) β-
oxidation, which is required for degradation of very long
chain fatty acids and pristanic acid, as well as the synthesis
of polyunsaturated fatty acids and bile acids and 3) ether
phospholipid synthesis which include plasmalogens.
To investigate the postnatal pathologies in the CNS, a
mouse model with neural selective peroxisome dysfunc-
tion was generated by breeding Nestin-Cre mice with
Pex5-loxP mice. In the latter mice the gene encoding the
import receptor of peroxisomal matrix proteins is floxed
[4]. This model shows a mild and temporary delay in neu-
rodevelopment [5] but from 3 weeks on Nestin-Pex5
knockout mice display motor and later on cognitive ab-
normalities, aggravating with increasing age and evolving
in immobility and death before the age of 6 months. In
brain, severe dys- and demyelination, astro- and micro-
gliosis and axonal damage were observed [4]. However,
the relationship between these anomalies and the precise
onset and progression of pathologies in different brain
areas were not elucidated. It was further demonstrated
that a similar but less aggressive phenotype develops in
mice with oligodendrocyte selective inactivation of Pex5
[6], whereas mice with neuron or astrocyte selective dele-
tion of functional peroxisomes were spared from demye-
lination, axon damage and astro- and microgliosis [7].
Gnpat−/− mice [8], which lack a crucial enzyme of
ether lipid synthesis, also exhibit a brain phenotype. The
cerebellar fibers display hypomyelination at the age of
3 weeks which does not aggravate at 6 weeks, based on
microscopical investigations and western blot analysis.
Significant dysmyelination was also observed in the
outer neocortical fibers of juvenile and adult (aged
8 months) Gnpat−/− mice. Furthermore, they display dis-
turbed axoglial contacts resulting in abnormal paranodal
organisation and axonal swellings [9]. In lipid raft micro-
domains (LRMs) isolated from myelin a significant re-
duction of LRM proteins was found, which was ascribed
to the severe lack of plasmalogens [8].
Also impaired peroxisomal β-oxidation causes a post-
natal phenotype in the CNS. Abcd1 knockout mice, a
model for the adrenomyeloneuropathy (AMN) form of
X-linked adrenoleukodystrophy (X-ALD), cannot trans-
port a subset of substrates over the peroxisomal mem-
brane, presumably saturated and/or unsaturated very
long chain fatty acid CoA esters. They develop a late
onset axonopathy in the spinal cord, but no brain
defects. Recently, oxidative stress was detected in spinal
cord of X-ALD mice, long before these mice develop
motor abnormalities [10]. Treatment with anti-oxidants
inhibited the development of oxidative stress and pre-
vented the development of motor disability and axonal
damage [11]. Furthermore, in brain-selective Pex13
knockout mice [12] increased superoxides and MnSOD
were detected in cerebellar cell cultures and up regula-
tion of MnSOD in the Purkinje cell layer of the cerebel-
lum in vivo.
Mice deficient in MFP-2 (also denoted as D-
bifunctional protein), carry a broader defect in peroxi-
somal β-oxidation, as this enzyme is necessary for the
degradation of both straight and branched chain sub-
strates [13]. They bear several similarities with Nestin-
Pex5 knockout mice in view of their motor defects and
early death. Marked astro- and microgliosis were
described [14] but no thorough study of myelinated
axons was performed.
Although we already reported on the pathology in the
end phase of disease of mice with peroxisome deficiency
in brain, the aim of the present investigation was to bet-
ter define the onset and progression of pathological
events in different brain areas of Nestin-Pex5−/− mice.
Therefore, immunofluorescent studies were performed
to (co)-localize myelin, axonal damage and neuroinflam-
matory markers. Furthermore, to better characterize the
inflammatory process and the status of microglial cells,
the mRNA expression of pro- and anti-inflammatory
markers was monitored. We also examined whether oxi-
dative stress could be a causative factor in disease onset
and progression. Finally, in order to define the role of
plasmalogen deficiency in the pathological events, Gnpat−/−
mice were directly compared with Nestin-Pex5−/− mice.
Methods
Mouse breeding
Nestin-Pex5 knockout mice and Gnpat−/− mice were
generated as previously described [4,8] and bred into a
Swiss Webster background. Tamoxifen inducible mice in
which the Cre-ERTM fusion protein is under the control
of the ubiquitously active CMV promoter [15] were
obtained from The Jackson Laboratory. Tamoxifen was
i.p. injected in CMV-Cre-ERTM-Pex5-loxP mice at the
age of 4 weeks at a dose of 0.2 mg/g body weight. All
mice received 5 injections, with one day intervals. Mice
were bred in the animal housing facility of the KULeu-
ven, had ad libitum access to water and standard rodent
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food, and were kept on a 12 h light and dark cycle. All
animal experiments were performed in accordance with
the “Guidelines for Care and Use of Experimental Ani-
mals” and fully approved by the Research Advisory
Committee (Research Ethical committee) of the K.U.
Leuven (#159/2008).
Treatment of the mice
Nestin-Pex5 mice were treated with anti-oxidants as
described [11]. N-acetylcysteine (1%) (Acros, Geel,
Belgium) was administered via the drinking water (pH
adjusted to 3.5) and α-lipoic acid (0.5% w/w) (Sigma-
Aldrich, Bornem, Belgium) via the food chow. Treat-
ment was started at the age of 3 weeks for a period of
9 weeks.
Immunohistochemistry
Paraffin sections were used for immunological detection
of almost all antigens, except for C1q, CC-1 and CNP,
for which cryosections were used. Stainings were done
according to [14]. The sources and concentrations of
antibodies are listed in Additional file 1: Table S1. For
each age, 3 to 5 individual knockout mice were analyzed
and compared with control littermates.
After incubation with primary antibodies overnight,
secondary HRP-labeled antibodies were applied during
1 h, followed by fluorescent labeling by the use of the
cyanine 2 (FITC) TSA kit (Perkin Elmer Life sciences,
Boston, USA). When double or triple immunolabeling was
performed, sets of primary and secondary antibodies were
sequentially applied. As a second and third fluorescent mar-
ker the cyanine 3 and cyanine 5 TSA kits (Perkin-Elmer)
were used.
Images were analyzed with a Zeiss CLSM510 confocal
laser scanning microscope equipped with a Zeiss axio-
cam camera.
Electron microscopy
After perfusion fixation of the corpus callosum with 2.5%
glutaraldehyde in 0.1 mol/L phosphate buffer pH 7.2, sam-
ples were kept in fixative at 4 ° C overnight. After 1 h post-
fixation in 2% osmium tetroxide/0.1 mol/L phosphate buf-
fer pH 7.2 at 4°C, the samples were dehydrated in graded
series of alcohol and embedded in epoxy resin. Ultra-thin
sections (50 to 60 nm) were cut, stained with uranyl acetate
and lead citrate and examined at 50 kV using a Zeiss EM
900 electron microscope (Oberkochen, Germany). Images
were recorded digitally with a Jenoptik Progress C14 cam-
era system (Jena, Germany) and operated using Image-Pro
express software (Media Cybernetics, USA).
RNA analysis
qRT-PCR on inflammatory markers was performed as
previously described [7]. The assay ID (Applied
Biosystems, Halle, Belgium) or the sequence of primers
and probes (when custom-made) are listed in Additional
file 2: Table S2. FIZZ1 (Mm00445109_m1) and IL10
(Mm00439616_m1) were designed and synthesized by
Applied Biosystems and purchased as a premix.
For microarray analysis, the transcriptional profiles of
hypothalamus of 10-week-old wild type and Nestin-Pex5−/−
mice (n=4 per genotype) were analyzed by using the whole
genome Affymetrix GeneChipW Mouse Genome 430 2.0
Array as described previously [16]. Labeling of the samples,
hybridization, washing and scanning of the chips was car-
ried out at the MicroArray Facility in Leuven (MAF, Leu-
ven, Belgium). The bioinformatics analysis was performed
as previously described [16]. The complete dataset is avail-
able under GEO record GSE1938.
Metabolic analyses
The TBARS assay to quantify the oxidative stress marker
malondialdehyde was performed as decribed [17]. Lipid
hydroperoxides were measured with xylenol orange
adapted from [18] Dried lipid extracts were redissolved
in 0.2 ml chloroform, followed by addition of 0.8 ml re-
action mixture (water/methanol 1/3, v/v), containing
32.25 mM H2SO4, 5 mM FeSO4, 250 μM xylenol orange
and 31.25 mM butyl hydroxytoluene. After incubation
for 30 min, absorbance was read at 560 nm and standar-
dized against cumene hydroperoxide.
Results
Demyelination and axon loss in cerebellum of young
Nestin-Pex5−/− mice is accompanied with mild gliosis
To allow co-localization of microgliosis, myelin abnormal-
ities and axonal damage in Nestin-Pex5 knockout mice,
triple immunofluorescent stainings were performed with
anti-F4/80, anti-MBP and either anti-APP (axonal swel-
lings, not shown) or SMI32 (nonphosphorylated neurofila-
ments, a sign of axonal degeneration). At 3 weeks, when
myelin formation is completed, all Nestin-Pex5−/− mice
showed strongly reduced MBP staining of the cerebellar
white matter in the folia, indicative of a lack of normal
myelin (Figure 1C–D). At the age of 2 weeks, the differ-
ence with control mice was less clear although some fibers
already lacked myelin in the cerebellar folia (Figure 1A–B).
With increasing age (Figure 1E–F), MBP staining of cere-
bellar axons further diminished, which was in accordance
with the appearance of degraded MBP (deMBP) (Additional
file 3: Figure S1A–C). Thus, there seems to be both a devel-
opmental and a stability problem for cerebellar myelin of
Nestin-Pex5 knockout mice. Damage to cerebellar axons
became apparent at 6 weeks by staining unphosphorylated
neurofilaments (Figure 1F). In addition, axonal swellings
were seen with the neurofilament marker SMI31
(Figure 1H, arrow), which also revealed marked axonal loss
from the age of 6 weeks on, in comparison with the wild
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type littermates (Figure 1G–I). At all stages, only a few F4/
80 positive microglial cells were associated with these fibers
lacking myelin (Figure 1A–F). Phagocytotic activity of
microglia was confirmed by increased staining for the
macrophage marker MAC-3 (Figure 1M) and for the lyso-
somal enzyme cathepsin D (not shown). Besides microglia,
Figure 1 (See legend on next page.)
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also astrocytes take part in the neuroinflammatory cascade.
Moderately increased GFAP immunoreactivity was
observed at 3 weeks in the white matter of the cerebellar
folia and in Bergmann glial cells of the molecular layer
(Figure 1J–K). At 12 weeks astrocytes had markedly prolif-
erated and showed a swollen morphology, indicative for
astrocyte activation (Figure 1L).
It is well known that paranodes and juxtaparanodes get
disorganized along demyelinated axons which according
to recent reports might even be an early event in Multiple
Sclerosis [19,20]. For this reason, paranodes and juxtapar-
anodes were visualized by antibodies against caspr and
potassium channels respectively. Already at the age of
3 weeks, potassium channels were more spread out over
cerebellar fibers, in comparison to the characteristic juxta-
paranodal distribution in control mice (Figure 1N–O).
Also in the cerebellar peduncles demyelination (Add-
itional file 4: Figure S2A–E) and axonal degeneration
(Additional file 4: Figure S2C–D, arrows and F–H) takes
place, respectively starting at 6 and 9 weeks and
aggravating with age. In contrast to the cerebellar folia,
marked microgliosis and macrophage activity was
observed at 12 weeks (Additional file 4: Figure S2E–F).
Cortex: Loss of myelin in the absence of a strong
microglial response
The development of pathology in the cortex strongly var-
ied from mouse to mouse but at the age of 12 weeks virtu-
ally all mice displayed a massive loss of myelin and axons.
A subset of mice displayed demyelination and microgliosis
between the age of 3 and 9 weeks, whereas others seemed
to be spared at this stage (Figure 2A–D; Additional file 3:
Figure S1G–I). Microgliosis is never pronounced, although
the few microglial cells are MAC-3 positive (Figure 2B),
are swollen and some of these cells contain MBP
(Figure 2D, arrow). Likewise astrogliosis is mild at all ages
analyzed (data not shown). Using anti-APP or SMI32
staining no axonal swellings were detected in the cortex.
However, despite the absence of these signs of axonal
damage, extensive axonal loss was observed with SMI31
immunohistochemistry in a subset of mice aged 3 to
9 weeks and from 12 weeks on in all mice (Figure 2E–F).
Brain stem and spinal cord: Strong correlation between
microglia activation and demyelination
In brain stem, both demyelination and axonal injury
were seen at a young age, but the onset varied between
3 and 6 weeks (Figure 3A–C). Early demyelination was
confirmed by deMBP staining, which was also seen at
higher ages (Additional file 3: Figure S1D–F). Damaged
SMI32 positive axons almost always lacked a MBP posi-
tive myelin sheet (Figure 3B–C). Moreover, proliferation
and activation of microglia appeared from the age of
3 weeks and became more pronounced than in cerebel-
lum. Microglial cells were often seen in the proximity of
damaged axons (Figure 3C, arrow) and often contained
myelin debris (Figure 3D–F, arrows). Astrocyte prolifera-
tion was weakly present from 3 to 9 weeks (not shown)
while at 12 weeks both astrocyte proliferation and acti-
vation were pronounced (Figure 3G–H). A similar onset
and progression of pathology was observed in the cer-
vical part of the spinal cord (not shown).
Inflammatory demyelination in corpus callosum
Although signs of demyelination and axon damage could
already be detected in corpus callosum of some 3- to 9-
week-old mice, a major loss of myelin and axons was
noticed in all 12-week-old mice (Figure 4A–D; Add-
itional file 3: Figure S1J–L). Similar as in the brain stem,
axonal swellings were mostly detected where myelin is
absent (Inset in Figure 4B, arrow). At this age myelin
loss was accompanied with disorganized juxtaparanodes
based on potassium channel stainings (Figure 4E–F,
arrow). Important to note is that demyelination in the
corpus callosum was always accompanied by extensive
microgliosis (Figure 4B) and phagocytotic activity (not
shown). A low grade of astrogliosis is seen from 3 to
9 weeks (not shown), but this worsened significantly
from 12 weeks on, and became more pronounced than
in all other brain areas (Figure 4H).
(See figure on previous page.)
Figure 1 Early myelin abnormalities but mild microgliosis in cerebellum. (A-F) Immunohistochemistry was performed to visualize microglia
(F4/80, green), damaged axons (SMI32, red) and myelin (MBP, blue). Compared to the control mice (A) several fibers in the cerebellar folia of the
Nestin-Pex5−/− already lack myelin at two weeks (B), which was even more pronounced at three weeks (C-D) and six weeks (E-F). SMI32 positive
axons, indicative of degeneration, were observed at six weeks (F). (G-I) Axonal loss was analyzed by the use of an antibody recognizing healthy
phosphorylated axons (SMI31). Decreased SMI31 immunoreactivity was observed at six (H) and 12 weeks (I), in comparison with the control
littermates (G). In addition, several axonal swellings were present (H-I, arrows). (J-L) Astrocytes were visualized by anti-GFAP, which revealed
higher immunoreactivity at three weeks in white matter of the folia, but also in the molecular layer (K). At 12 weeks astrocyte proliferation and
activation was even more pronounced (L). (M) Double labeling of myelin (MBP, blue) and activated/phagocytotic microglia with MAC-3 (green) in
the cerebellum of a nine-week-old Nestin-Pex5−/− mouse. (N-O) An antibody specific for potassium channels (K+) was used for the investigation of
paranodal structures. Cerebellar axons displayed an abnormal distribution of potassium channels (O, arrows), as compared to the strict
juxtaparanodal localization in the control (N). All panels of each row were stained with the same antibodies. Scale bars: A-M: 100 μm; N-O: 10 μm.
GFAP: glial fibrillary acidic protein, K+: potassium, MAC: macrophage, MBP: myelin basic protein, SMI: Sternberger Monoclonals Inc.
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Electron microscopy (EM) of the corpus callosum of
Nestin-Pex5 knockout mice was performed to comple-
ment the fluorescence microscopy. The ultrastructure of
the corpus callosum of control mice (Figure 5A) showed
cross and longitudinal sections of axons with a regular
and compact myelin sheath. Nestin-Pex5 knockout mice
of 3 weeks (Figure 5B) showed axons with normal mye-
lin sheaths but also denuded axons. Some axons dis-
played a swollen necrotic cytoplasm which was still
enwrapped by a clear myelin sheath (arrow). At 12 weeks
(Figure 5C) axonal injury became more apparent
showing completely necrotic areas with remnants of
cytoplasmic organelles and cytoskeleton elements (as-
terisk). Again it is important to note that several
oedematous axons are still myelinated (arrow). Taken
together, degeneration of myelinated axons in corpus
callosum can already be detected by EM analysis at the
age of 3 weeks. This strongly aggravates with age
Figure 2 Myelin loss and mild microgliosis in the cortex. (A-D) Double immunolabeling of myelin (MBP, red) and activated microglia (MAC-3,
green) or microglia (F4/80, green), respectively. Cortical demyelination was detected in a subset of Nestin-Pex5−/− mice at six weeks (B and D), but
a strong microglial reaction was never seen (B and D). However, the observed microglial cells were MAC-3 positive, which indicates phagocytotic
activity (B) and some microglia seem to contain myelin (D, arrow). (E-F) Loss of axons, represented as a decreased SMI31 immunoreactivity, was
clearly detectable in the cortex of 12-week-old knockout mice (F), when compared to the control mice (E). All panels of each row were stained
with the same antibodies. Scale bars: A-C and G-I: 100 μm; D-F: 25 μm. MBP, myelin basic protein.
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which then can be visualized with immunofluorescent
stainings.
Activation of the immune system in nestin-Pex5 knockout
mice
To obtain an overall picture of altered gene expression
in peroxisome deficient brain, microarray analysis was
performed. Hypothalamus tissue of 10-week-old mice
was chosen because this brain area can be easily deli-
neated and pathology is progressing at this age based on
histological observations. The KEGG pathways that were
most significantly up regulated are all related to immune
responses, including cytokine-cytokine receptor inter-
action, transendothelial migration, antigen processing
and presentation, and toll-like receptor signaling
pathways (Table 1). In order to confirm these data, the
expression of a selection of inflammatory markers was
evaluated in other brain areas and at other time points
by qRT-PCR and by immunofluorescence.
Based on the microarray results, mRNA levels of sev-
eral components of the complement system are highly
up regulated. C1q, one of the most markedly up regu-
lated genes, is the first subcomponent of the classical
complement system and was further investigated by
qRT-PCR. Strikingly, C1q mRNA levels were already sig-
nificantly elevated at 3 weeks, and increased dramatically
with age in corpus callosum (Figure 6A). In contrast, in
cerebellum C1q transcripts were only mildly up regu-
lated (Table 2). In order to localize C1q expression,
immunohistochemistry on sagittal brain sections was
Figure 3 Association of severe demyelination with extensive microgliosis in the brain stem. (A-C) Triple staining of microglia (F4/80,
green), damaged axons (SMI32, red) and myelin (MBP, blue). Already at the age of three and six weeks demyelinated and degenerating axons are
observed in a subset of Nestin-Pex5−/− mice (B-C), in contrast with the control littermates (A). Microglial cells are observed in association with
these demyelinated axons (C, arrow). (D-F) Higher magnification of the double labeling of myelin (MBP, red) and microglia (F4/80, green) in the
brain stem of six- to nine-week-old Nestin-Pex5−/− mice. The observed microglial cells have a swollen appearance and several of them contain
MBP-positive myelin debris (D-F, arrows). (G-I) The anti-GFAP antibody was used to analyze astrogliosis, which is mild at three weeks (H), but
strongly pronounced at 12 weeks (I), compared with the control mice (G). All panels of each row were stained with the same antibodies. Scale
bars: A-D and G-I: 100 μm; E-F: 50 μm. GFAP, glial fibrillary acid protein; MBP, myelin basic protein.
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performed. C1q immunoreactivity was already increased
at the age of 3 and 6 weeks in brain stem (Figure 6C)
and at 6 weeks in corpus callosum (Figure 6D), preced-
ing the detection of microgliosis by F4/80 in these brain
areas. In accordance with the mRNA data, no C1q
deposits were found in cerebellum (Figure 6E). As it was
previously shown that C1q can be expressed by different
cell types, co-localization studies were performed. There
is no overlap of C1q with F4/80, suggesting that this
complement factor is not expressed by microglia at
6 weeks (Figure 6C and E). Partial overlap is seen with
CC-1 (Figure 6D, arrows), a marker for oligodendrocyte
cell bodies. The cellular C1q deposits did not overlap
with myelin sheaths or axons, but based on the shape of
the immunoreactive structures the majority of C1q was
present on the surface of neuronal cell bodies (not shown),
although we could not determine the localization by double
stainings.
Other pro-inflammatory markers, including TNFα, the
toll-like receptor TLR2 and the chemokine Cxcl-1, were
analyzed by qRT-PCR in corpus callosum of 3- and 6-
week-old mice (Figure 7A-B) and in cerebellum of 6-
week-old mice (Table 2). All these inflammatory media-
tors were highly up regulated even before demyelination,
axonal pathology and microgliosis are detectable by
fluorescence microscopy. This is particularly obvious in
corpus callosum, where expression of pro-inflammatory
markers is strongly increased at 6 weeks, whereas the
peak of microglia activation only occurs from 12 weeks
on.
Importantly, the microarray data also pointed to pha-
gocytotic activity of inflammatory cells in the brain of
10-week-old Nestin-Pex5−/− mice (Table 1), confirming
histological results. Receptors involved in the binding
and ingestion of pathogens, including Fc receptors, com-
plement receptors and P2Y6 were highly up regulated
(Table 1). The latter receptor recognizes the nucleotide
UDP released from injured neurons and stimulates
phagocytosis [21]. Furthermore, expression of Mpeg1, a
macrophage marker [22] and of lysosomal proteins, were
significantly increased. Examples are cathepsin D (2.54
fold up regulated), Lamp2 (1.57 fold) and hexosamini-
dase B (3.17 fold). This was further confirmed by qRT-
PCR on Mpeg1 in other brain regions and at earlier time
points (Figure 7A and B; Table 2).
In a normal inflammatory process, a pro-inflammatory
phase is followed by a resolution phase, during which
microglial cells produce anti-inflammatory markers
Figure 4 Corpus callosum is affected later than other brain regions. (A-B) Microglia (F4/80, green), axonal swellings (APP, red) or damage
(SMI32, red) and myelin (MBP, blue) were co-labeled on sagittal brain section. At six weeks no pathology was observed yet in the corpus
callosum, but at 12 weeks demyelination was pronounced and associated with microgliosis (B) and axonal swellings (Inset in B, arrow). (C-D)
Healthy axons were massively lost at 12 weeks, as shown by decreased SMI31 immunoreactivity (D), compared to control mice (C). (E-F)
Potassium channels (K+) were immunolabeled to visualize the juxtaparanodes. In the 12-week-old Nestin-Pex5−/− mice these juxtaparanodes
displayed a broader distribution (F, arrow), in comparison with the control mice (E). (G-H) Astrocytes were labeled with anti-GFAP. Astrogliosis is
strongly pronounced at 12 weeks (H), in comparison with the control mouse (G). Scale bars: A-D: 100 μm; G-H: 10 μm; Inset in B: 12 μm. APP:
amyloid precursor protein, GFAP: glial fibrillary acidic protein, K+: potassium, MBP: myelin basic protein, SMI: Sternberger monoclonals Inc.
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[23,24]. According to microarray analysis only TGFβ and
Heme oxygenase-1 were up regulated (2.54 and 2.37 fold
respectively) (Table 2). However, additional anti-
inflammatory markers [25] were analysed by qRT-PCR
analysis in corpus callosum of 3- and 6-week-old mice.
As Arginase 1, Fizz1, IL10 and TGFβ were all
Figure 5 Ultrastructure of myelin and axons in corpus callosum. (A) Cross and longitudinal sections of nerve fibers of control mice display a
regular and compact myelin sheath. (B) In the corpus callosum of three-week-old Nestin-Pex5−/− mice many axons are still myelinated while a
subset already lacks a myelin sheath. The arrow in (B) indicates a swollen necrotic axon, surrounded by a normally appearing myelin sheath. (C) In
12-week-old Nestin-Pex5 knockout mice demyelination is even more pronounced than at three weeks. Similarly as at three weeks, an edematous
necrotic axon, which is enwrapped by an apparently normal myelin sheath (arrow), is detected. In addition, large necrotic areas are observed
(asterisk).
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Table 1 Microarray analysis on hypothalamus of 10-week-old Nestin-Pex5−/− mice
Cytokine-cytokine receptor interaction
Complement Fold change
C3ar1 complement component 3a receptor 1 11.28***
C1qb complement component 1, q subcomponent, beta polypeptide 9.4***
C4b complement component 4B 8.47***
C1qa complement component 1, q subcomponent, alpha polypeptide 7.64***
Chemokines
Cxcl13 chemokine (C-X-C motif) ligand 13 16.8***
Ccl6 chemokine (C-C motif) ligand 6 11.93***
Ccl3 chemokine (C-C motif) ligand 3 8.13***
IL12b Interleukin 12b 5.67***
Leukocyte transedothelial migration
Itgb2 Integrin beta 2 5.57***
Itgam Integrin alpha M 3.56***
ICAM1 Intercellular adhesion molecule 1 4.12***
VCAM1 Vascular cell adhesion molecule 1 1.52***
Antigen processing and presentation
H2-K1 Histocompatibility 2, K1, K region 5.57***
H2-D1 Histocompatibility 2, D region locus 1 3.56***
Fcgr2b Fc receptor, IgG, low affinity IIb 6.21***
Fcgr3 Fc receptor, IgG, low affinity III 4.41***
P2Y6 Pyrimidinergic receptor P2Y, G-protein coupled 6 5.22***
B2m beta-2 microglobulin 3.06***
Ctse cathepsin E 1.52***
Toll-like receptor signaling pathway
TLR2 Toll-like receptor 2 4.70***
TLR1 Toll-like receptor 1 4.43***
TLR7 Toll-like receptor 7 1.98***
TLR4 Toll-like receptor 4 1.70***
Anti-inflammatory markers
IL4 Interleukin 4 0.93
IL10 Interleukin 10 1.03
IL13 Interleukin 13 1.01
Arg1 Arginase-1 1.13
TGFβ Transforming growth factor β 2.54***
HO-1 Heme oxygenase-1 2.37***
Anti-oxidantia
Cat Catalase 1.23*
MnSOD Manganese superoxide dismutase 0.95
Prdx6 Peroxiredoxin 6 1.34***
Prdx1 Peroxiredoxin 1 1.12*
Gpx1 Glutathione peroxidase 1 1.25***
Only the most affected KEGG pathways are represented. Values are given as means of 4 independent samples. * p< 0.05, *** p< 0.001.
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significantly up regulated in 6-week-old Nestin-Pex5−/−
mice, it appears that the pro-inflammatory response is
accompanied by an anti-inflammatory reaction. In cere-
bellum of 6-week-old Nestin-Pex5−/− mice, only TGFβ is
significantly elevated, the other anti-inflammatory mar-
kers were not (Table 2).
The microarray results further revealed the up regula-
tion of genes involved in transendothelial migration of
blood-derived inflammatory cells into the brain. To verify
increased infiltration, immunohistochemistry with an
antibody recognizing T-cells (CD3) was performed. At
the age of 12 weeks a limited number of T-cells were
noticed in corpus callosum of Nestin-Pex5−/− mice
(Figure 7C–D).
Together, these data indicate that the innate immune
system is activated at a very early stage in peroxisome
deficient brain, generating a strong and persistent pro-
inflammatory response which could not be stopped by
Figure 6 C1q expression is an early response in Nestin-Pex5−/− brain. (A) C1q expression levels were quantified by qRT-PCR. Up regulation
of mRNA levels was already significant in the corpus callosum of the three-week-old Nestin-Pex5−/−, although this was much more pronounced at
six weeks. Expression levels were normalized to β-actin expression. Values are given as means ± SEM of four independent samples. ** P< 0.01, ***
P< 0.001 (Student’s t-test). (B-E) C1q was also investigated by immunohistochemistry. At six weeks, C1q immunoreactivity was observed in the
corpus callosum (D) and brain stem (C), but not in the cerebellum (E). Double labeling of C1q (green) and microglia (F4/80, red) or
oligodendrocytes (CC-1, red), respectively, was performed to determine the cellular localization of the complement protein. C1q was not present
in microglia (B and D), but in a subset of oligodendrocytes (C). Scale bars: B and E: 50 μm; C and D: 20 μm. SEM, standard error of the mean.
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anti-inflammatory mechanisms. Secondarily, the adap-
tive immune system is activated.
Oxidative stress
Because it was reported that oxidative stress precedes
the axon pathology in spinal cord of Abcd1 knockout
mice, lacking the peroxisomal transporter ABCD1
[10,11], several experiments were conducted to investi-
gate whether oxidative stress occurs in Nestin-Pex5
knockouts. The TBARS assay was performed to detect
end markers of lipid peroxidation, predominantly mal-
ondialdehyde, in the CNS of Nestin-Pex5 mice
(Figure 8A). Furthermore, lipid hydroperoxides were
quantified using xylenol orange. No evidence for lipid
peroxidation was found in corpus callosum, cerebellum
and spinal cord of 9- to 12-week-old knockout mice
(data not shown).
As it was reported that immunohistochemistry is a
more sensitive procedure to detect markers of oxidative
stress in brain [26], stainings were performed with anti-
bodies reacting with 4-hydroxynonenal (4-HNE). Slightly
higher 4-HNE immunoreactivity was detected in Pur-
kinje cells already at postnatal day 14 (Figure 8B–C)
which increased with age (Figure 8D–E). In addition, 4-
HNE staining was sporadically observed along cortical
fibers and in the corpus callosum but not in all mice
and not at all ages tested (not shown). In all the other
brain regions and cell types, there was no difference in
immunoreactivity between Nestin-Pex5−/− and control
mice. To confirm these findings, oxidative damage to
proteins was examined by staining with antibodies to 3-
nitrotyrosine [27]. Immunoreactivity was also elevated in
Purkinje cells of Nestin-Pex5−/− mice, starting at 3 weeks
(Figure 8F–G) and increasing with age (Figure 8H–I),
but not in other brain regions. Interestingly, according
to microarray data there is no up regulation of the cyto-
kine iNOS in Nestin-Pex5−/− mice, which was confirmed
by qRT-PCR analysis in corpus callosum of 6-week-old
mice (not shown). In agreement with iNOS, also mRNA
levels of NADPH oxidase were not altered in the micro-
array. However, at the age of 5 months significantly
higher levels of iNOS were detected in corpus callosum
(2.35 fold, p< 0.05). At this age, also 4-HNE immunor-
eactivity was observed in corpus callosum of a subset of
Nestin-Pex5−/− mice.
Up regulation of anti-oxidative enzymes is another in-
dicator of increased oxidative stress. According to
microarray analysis the peroxiredoxins 1 and 6, catalase
and glutathione peroxidase 1 were mildly but signifi-
cantly up regulated, whereas several other ones such as
MnSOD were not. MnSOD immunoreactivity was also
not different between brains of Nestin-Pex5−/− mice and
control littermates (Table 1). Strongly increased catalase
immunoreactivity in Nestin-Pex5 knockouts was already
reported [4].
To rule out that a low level of oxidative stress, that
was not detectable with the used methods, contributes
to the pathology, Nestin-Pex5−/− mice were treated from
the age of 3 weeks for a period of 9 weeks with an anti-
oxidant mixture of α-lipoic acid (0.5% w/w in food
chow) and N-acetylcysteine (1% in drinking water). This
treatment did not lead to improvement of the motor
performance and health status of the mice. Microscopic-
ally, catalase levels were not reduced and 4-HNE was
still detected in Purkinje cells of treated Nestin-Pex5−/−
mice. Thus, anti-oxidative treatment did not affect the
phenotype of Nestin-Pex5 knockout mice.
No neuroinflammation in the gnpat knockout model
One of the major peroxisomal metabolic pathways is the
synthesis of ether lipids, including plasmalogens which
are very enriched in brain myelin. It was previously
reported that cerebellar and neocortical dysmyelination
occurs in juvenile Gnpat knockout mice, a model with
selective ether lipid deficiency [9]. In order to examine
the contribution of deficient ether lipid synthesis to the
pathology of Nestin-Pex5 knockout mice, the two mod-
els were directly compared. These two models show a
similar premature death rate, with a critical period be-
tween P1 (postnatal day 1) and weaning when 30 – 50%
of the knockouts die. However, Gnpat knockout mice can
survive more than 20 months, whereas Nestin-Pex5−/− mice
always die before the age of 6 months. First we analyzed
the levels of plasmalogens in the brains of both models at
3 weeks. Whereas plasmalogen levels are 15-fold lower in
the Nestin-Pex5 knockout brain in comparison to controls
(0.6 nmol/mg tissue vs 9.8 nmol/mg) plasmalogen levels
were even further reduced below the detection level
(< 0.03 nmol/mg tissue) in Gnpat−/− mice.
Next, immunhistochemical analyses were performed
on brain sections of Gnpat−/− mice at the age of 3 and
Table 2 Fold change of mRNA levels of inflammatory
mediators incorpus callosum and cerebellum of 6-week-
old Nestin-Pex5 mice
Nestin-Pex5 6 weeks
Fold change Corpus callosum Cerebellum
TNFα 28.96 ± 6.27*** 17.15 ± 8.85
C1q 8.40 ± 1.43*** 2.94 ± 1.45
TLR2 11.91 ± 3.26*** 12.42 ± 6.10
Mpeg1 13.64 ± 6.38*** 10.63 ± 0.34***
TGFβ 2.83 ± 0.18*** 3.38 ± 0.5**
IL10 30.92 ± 10.65* 3.18 ± 3.10
Arg1 1.78 ± 0.08** 2.78 ± 1.11
Fizz1 13.31 ± 8.59 1.62 ± 0.50
Values represent means of 4 independent samples. * p< 0.05, ** p< 0.01,
*** p< 0.001. Expression levels were normalized to β-actin expression.
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12 weeks and 5 months. At the age of 3 weeks, MBP
staining is diminished in cerebellum, similar to the
reduced staining in 3-week-old Nestin-Pex5 knockouts.
However, at 12 weeks and 5 months, myelin levels did
not further decrease in Gnpat−/− mice (Figure 9A–B).
Subtle axonal loss was observed in this brain area at
3 weeks (Figure 9C) by SMI31 staining and occasionally
at 12 weeks and 5 months (Figure 9E–F). As previously
reported [9], axonal swellings were observed on Purkinje
cell axons (Figure 9F, arrow and inset), the abundance of
Figure 7 (See legend on next page.)
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Figure 8 (See legend on next page.)
(See figure on previous page.)
Figure 7 Up regulation of pro- and anti-inflammatory markers in Nestin-Pex5−/− mice. (A-B) In the corpus callosum of three- and six-week-
old Nestin-Pex5−/− mice mRNA levels of several pro- and anti-inflammatory markers were quantified by qRT-PCR. (A) TNFα***, Cxcl-1*, Mpeg1**
and TLR2* were all significantly up regulated in the corpus callosum of three-week-old knockout mice. The anti-inflammatory markers TGFβ, IL10,
arginase 1 and FIZZ1 were not up regulated at three weeks. (B) At six weeks the pro-inflammatory markers showed much higher expression
levels, compared to three-week-old Nestin-Pex5 knockout mice. Also expression levels of the anti-inflammatory markers TGFβ, IL10 and arginase 1
were significantly increased at this age. Values represent means ± SEM of four independent samples, * P< 0.05, ** P< 0.01, *** P< 0.001
(Student’s t-test). Expression levels were normalized to β-actin expression. (C-D) By immunohistochemistry infiltration of CD3 positive lymphocytes
was observed in 12-week-old Nestin-Pex5−/−mice, mainly in the corpus callosum. Scale bars: C: 50 μm; D: 25 μm. CD: cluster of differentiation, Cxcl:
chemokine (C-X-C motif) ligand, FIZZ: found in inflammatory zone, IL: interleukin, Mpeg: macrophage expressed gene, SEM: standard error of the
mean, TGF: transforming growth factor, TLR: toll like receptor.
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which strongly correlated with the ataxic behavior of
Gnpat−/− mice.
In the cortex, some Gnpat knockout mice (aged
3 weeks – 5 months) also displayed reduced MBP immu-
noreactivity (Figure 9G–H), which however never reached
the level of cortical demyelination of 12-week-old Nestin-
Pex5−/− mice. In general, the lack of myelin and axonal loss
in the Gnpat−/− is clearly less drastic, compared to the Nes-
tin-Pex5−/− mice and restricted to the neocortex and cere-
bellum at all ages analyzed. Microgliosis was not observed
in the knockout mice whereas a slightly increased number
of astrocytes was noticed at 3 months in the white matter
of the cerebellar folia and at 3 and 5 months in the brain
stem (not shown). To investigate whether the innate im-
mune system was activated, inflammatory markers were
analyzed in the forebrain and brain stem of 4-month-old
Gnpat−/− mice, but, remarkably, pro-inflammatory cyto-
kines were not induced (Figure 9M).
Markers of oxidative stress were investigated by
immunohistochemistry. Similar to the Nestin-Pex5−/−
mice, an increased immunoreactivity for 3-nitrotyrosine
(Figure 9I–J) and a slightly higher reactivity for 4-HNE
was detected in Purkinje cells of 3-week-old Gnpat−/−
mice (Figure 10 K-L). At 12 weeks and 5 months, only a
subset of knockout brains stained positive for 3-
nitrotyrosine and 4-HNE in Purkinje cells. Higher pro-
tein levels of catalase were also detected in the Gnpat
knockout, but this was only observed in the white mat-
ter and Bergmann glial cells of the cerebellum and not
in the cerebrum. This is in contrast to Nestin-Pex5−/−
where higher catalase levels were seen throughout the
brain [4]. Summarizing, despite a more severe deficiency
of plasmalogens as compared to Nestin-Pex5−/− mice,
Gnpat−/− mice do not develop an inflammatory pheno-
type, nor extensive demyelination and axonal loss.
Inactivation of peroxisomes after development causes
similar pathology as the nestin-Pex5−/−
To exclude that the brain phenotype of Nestin-Pex5−/−
mice is somehow a consequence of mild developmental
delays [5], a mouse model was investigated in which CNS
peroxisomes were inactivated at a later time point. To this
end, CMV-Cre-ERTM mice, in which the expression of
Cre-recombinase fused to a mutated estrogen receptor
ligand binding domain is driven by the ubiquitously active
CMV promoter, were bred with Pex5-loxP mice. After ad-
ministration of tamoxifen at the age of 4 weeks, the Cre
recombinase fusion protein becomes activated causing
Pex5 recombination. As previously shown (paper submit-
ted, supplemental Figure 3), wild type PEX5p was not
completely lost in all tissues, but inactivation was particu-
larly effective in brain (less than 20% wild type Pex5
mRNA). Based on the cytosolic pattern of catalase, pre-
dominantly astrocytes and oligodendrocytes and some
microglia were devoid of functional peroxisomes, whereas
most neurons still contained a peroxisomal catalase stain-
ing (Additional file 5: Figure S3, arrows).
These mice developed significant motor problems
from the age of 5 months which gradually aggravated
with age, leading to death from the age of 8 months.
This is similar to Nestin-Pex5−/− mice although with a
later onset and a slower progression (Additional file 6:
Figure S4A). Immunohistochemistry at 3, 5 and 8 months
of age revealed that brain pathologies developed in the
same sequence and in the same brain regions as in Nestin-
Pex5−/− mice but with later onset. Microgliosis was mildly
present in a subset of knockouts at 3 months, mainly in
the cerebellum and the brain stem (not shown). However,
it became more pronounced at 5 and 8 months in those
brain regions (cerebellum, Additional file 4: Figure S4Ba-c).
Microgliosis coincided with demyelination (Additional file
4: Figure S4Ba-c) and axonal damage (Additional file 4:
Figure S4Bb), axonal loss (Additional file 4: Figure S4Bd–e)
and swellings (Additional file 4: Figure S4Bf, arrow), which
is the most pronounced at 8 months of age in these areas.
Demyelination was confirmed by the presence of deMBP
in the cerebellar folia (not shown). As in the Nestin-Pex5−/−
mice the corpus callosum was affected later than other
brain regions, displaying microgliosis between 5 and
8 months, but no demyelination or axonal damage (Add-
itional file 4: Figure S4Bg–i).
Thus, loss of functional peroxisomes from brain at any
age induces a neurodegenerative program accompanied
with a strong inflammatory response.
Discussion
Absence of functional peroxisomes in the postnatal
mouse CNS causes a neurodegenerative phenotype that
(See figure on previous page.)
Figure 8 Oxidative stress markers are only present in Purkinje cells. (A) End products of lipid peroxidation, predominantly malondialdehyde,
were quantified by the TBARS assay. No differences between 9- to 12-week-old Nestin-Pex5−/− and control littermates were observed in the
corpus callosum, cerebellum or spinal cord. Values are given as means ± SEM of four independent samples of each genotype (Student’s t-test). (B-I)
The markers 4-HNE (B-E) and 3-nitrotyrosine (3-NT) (F-I) were evaluated by immunohistochemistry. 4-HNE was slightly observable in Purkinje cells of two-
week-old Nestin-Pex5−/− mice (C), compared with the control littermates (B). The amount of 4-HNE present in Purkinje cells was higher at three (D) and
12 weeks (E). Low 3-NT immunoreactivity was observed at three weeks in Purkinje cells (G), but increased with age (H-I). Scale bars: B-F and G: 100 μm; G
and I: 50 μm. 4-HNE, 4-hydroxynonenal; SEM, standard error of the mean; TBARS, thiobarbituric acid reactive substances.
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ultimately leads to extensive axon loss and early
death. This closely mimics pathologies in mild per-
oxisome biogenesis disorders and the cerebral form
of X-ALD. We here investigated the involvement of
micro- and astroglia activation, metabolic factors and
oxidative stress in the onset and progression of mye-
lin and axon loss triggered by peroxisome inactivity.
In all demyelinating areas, increased numbers of
microglia were present. Remarkably, in cerebellum and
cortex microglia were never very abundant, whereas they
Figure 9 (See legend on next page.)
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were strongly represented in brain stem starting in the
juvenile period and they massively invaded the demye-
linating corpus callosum of 12-week-old mice. Also of
note is that astroglial activation lagged behind microglia
proliferation, as described before in other neurodegen-
erative diseases [28]. Many microglia displayed features
of phagocytosing cells including a swollen appearance,
sometimes containing MBP-positive myelin debris and
surrounding a demyelinating fiber. This was also con-
firmed by increased transcripts for macrophage markers
such as Mpeg1 and lysosomal enzymes.
According to recent insights, the number and shape of
microglia does not predict the type of immunological re-
action that is developing. Besides the classical pro-
inflammatory microglia, macrophages occur that are
involved in the resolution of inflammation which have
been named “alternatively activated” or “deactivated”
[29]. In all brain regions, markers of a pro-inflammatory
response, such as TNFα, IL6 and IL1β were highly up
regulated [30]. Although both markers of alternative
microglial activation (Arginase 1, Fizz1) and of acquired
deactivation (IL10, TGFβ) were up regulated in peroxi-
some deficient corpus callosum before the peak of
microglial activation occurred, this could not halt the
progression of inflammation.
It was remarkable that the induction of markers of the
innate immune system occurred at a very early stage in
the disease process, within 3 weeks after birth. Strikingly,
it was recently reported that peroxisome deficiency in
Pex1 mutant Drosophila larvae also caused up regulation
of genes involved in innate immunity, further supporting
that peroxisome deficiency modulates immunological
responses [31]. In addition, peroxisomes were shown to
be involved in the generation of defense factors follow-
ing a viral infection and thus participate in antiviral sig-
naling [32]. The precise role of peroxisomes in shaping
the innate immune responses will need to be further
elucidated.
With regard to neuronal morphology, we did not find
much evidence for cell death [4] but there was progressive
axonal loss throughout the CNS which was already very
obvious at the age of 12 weeks based on neurofilament
staining with antibody SMI31. At this and earlier ages,
axonal swellings (detected by staining with anti-APP) and
damage (detected by staining unphosphorylated neurofila-
ments with SMI32) could be visualized, but these stainings
strongly underestimated ongoing axonal degeneration. By
EM analysis, some axonal irregularities were already
observed at the age of 3 weeks, illustrating the very early
onset of the degenerative phenotype. The progressive
axonal loss coincided with severe and progressive motor
and cognitive decline, which we reported before [4]. In
this respect, it is interesting to mention that axonal injury
is currently considered as the most important cause of
clinical disabilities in MS [33,34].
With the exception of a variable onset of lesions in the
cortex, the development of brain pathology was consist-
ent from mouse to mouse. It was also recapitulated, but
delayed in time, in mice in which peroxisomes were
deleted from the CNS in the juvenile period after com-
pletion of myelination. This ruled out the possibility that
the observed anomalies were a late consequence of per-
oxisome ablation during development. Our present find-
ings that demyelination in cerebellum precedes white
matter abnormalities in cerebrum is in striking agree-
ment with reports in mildly affected peroxisome biogen-
esis patients [35,36] in which regressive changes
predominate over developmental anomalies. By MRI
analysis the first foci of white matter abnormalities were
found in the central cerebellar area, additional lesions
were often seen in the brain stem whereas the cerebral
hemispheres were affected later. This distribution of
white matter lesions is clearly different from the typical
pattern in X-ALD in which the splenium of the corpus
callosum is affected first. Remarkably, the leukoencepha-
lopathy in PBD patients was not predictive for the clin-
ical outcome [35] suggesting that additional pathology
causes the psychomotor retardation. In addition, patients
have been identified with milder PEX mutations, display-
ing normal mental capacities, but developing progressive
ataxia, caused by cerebellar atrophy [36-38]. Why cere-
bellar neurons are selectively affected in these longer
surviving patients is not clear.
A direct comparison of the lesions in Nestin-Pex5−/−
mice with those in Gnpat−/− mice allowed to determine
the contribution of hampered ether phospholipid
(See figure on previous page.)
Figure 9 Cerebellar and cortical dysmyelination in Gnpat−/− mice in the absence of microglia activation. (A-L) Immunohistochemistry was
performed to investigate myelin (MBP), axonal loss (SMI31), microgliosis (F4/80) and oxidative stress (4-HNE and 3-nitrotyrosine). Gnpat−/− mice
displayed a decreased amount of myelin in the cerebellar folia at three months (B), compared with the control littermates (A). Cortical
demyelination was observed in a subset of three-month-old Gnpat knockout mice (G-H). Axonal loss was very mild at three weeks (C-D) and five
months (E-F) and also a few axonal swellings were detectable with SMI31 (red) at five months (F, arrow and inset). Microgliosis (F4/80, green) was
absent (F). 3-Nitrotyrosine (3-NT) and 4-HNE positive Purkinje cells were seen in three-week-old Gnpat−/− mice (J, L), in comparison with the
control mice (I, K). Scale bars: A-F and I-L: 100 μm; G-H: 50 μm. (M) Quantification of mRNA levels of the pro-inflammatory markers TNFα, TLR2
and C1q by qRT-PCR. Expression levels were not elevated in four- to five-month-old Gnpat knockout mice. Values represent means ± SEM of four
independent samples. Expression levels were normalized to β-actin expression. 4-HNE, 4-hydroxynonenal; TLR2, toll-like receptor 2; SEM, standard
error of the mean.
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synthesis to the observed pathologies. Ether phospholi-
pids are quintessential products of peroxisomal metabol-
ism that are very enriched in the CNS and myelin under
the form of plasmalogens. Gnpat−/− mice were previ-
ously shown to have myelin deficits in cerebellum and
swellings on Purkinje cell axons [9]. Although the pat-
tern of hypomyelination, axonal swellings and axonal
loss was very similar in cerebellum of juvenile Gnpat
and Nestin-Pex5 knockout mice, with increasing age,
Gnpat−/− mice did not further lose myelin in cerebellum,
nor in other brain areas. Also in rhizomelic chondrodys-
plasia punctata RCDP patients, abnormalities in white
matter were reported which were however rather located
in supratentorial areas [39]. In sharp contrast with Nestin-
Pex5 knockout mice no phagocytotic microglia nor re-
active astrocytes were detected at the age of 6 months
throughout the Gnpat−/− brain which was further con-
firmed by the absence of pro-inflammatory markers.
These findings are in accordance with the pathology
observed in the Pex7−/− mouse model for RCDP type 1.
At the age of 9 – 11 months the latter mice do not dis-
play a reactive response of microglia [40] but they show
mild astrocytosis. Likewise, in RCDP patients non-
inflammatory dysmyelination and occasionally astrocy-
tosis, but no inflammatory demyelination has been
reported [41]. A mild degree of gliosis is observed in a
case of GNPAT deficiency [42]. In view of the inflamma-
tory demyelination in patients with peroxisomal β-
oxidation deficiency [43], the latter metabolic defect is
likely facilitating the inflammatory response in brain
lacking peroxisomes. Extensive gliosis was indeed
observed in Mfp2 knockout mice although the pro- ver-
sus anti-inflammatory character was not investigated
yet. A role for plasmalogen shortage as a factor syner-
gizing with peroxisomal β-oxidation defects to induce
inflammation can however not be excluded. Indeed,
microglia activation was observed in the Pex7:Abcd1
double knockout mouse model but not in the single
knockouts [40].
An important question is whether the axon injury cul-
minating in axonal loss is due to myelin abnormalities,
to neuroinflammation, to other factors, or a combination
of these. We can indeed exclude that this is the conse-
quence of peroxisome deficiency within neurons, as we
previously showed that neuron selective inactivation of
Pex5 did not cause a neurodegenerative phenotype [7].
Based on fluorescence microscopy, and particularly obvi-
ous in cerebellum, axonal swellings and degeneration
mostly appear after demyelination, indicating that the
lack of myelin evokes loss of the denuded axon. On the
other hand, as previously reported and now confirmed
at younger ages, ultrastructural analysis showed degener-
ating axons that were still surrounded by a full myelin
sheath, indicating that alternative mechanisms may also
be operating. The milder phenotype of Gnpat knockout
mice, in which an inflammatory reaction is absent,
strongly indicates that the early and severe activation of
the innate immune system contributes to the neurode-
generative phenotype in Nestin-Pex5−/− mice. The detri-
mental impact of neuroinflammation on axonal survival
is well established. In MS patients, axonal loss is closely
related to the degree of inflammation in the active
lesions [34,44]. In addition, it should be kept in mind
that peroxisomes play an essential role in oligodendro-
cytes, because the selective loss of functional peroxi-
somes from these cells also results in inflammatory
demyelination [6]. In this respect the early expression of
the complement component C1q on oligodendrocytes
and neurons might be indicative of an endangered re-
sponse which secondarily evokes inflammation. Indeed,
although the complement system can be stimulated by
both the innate and the adaptive immune system, it here
seems to play a role in the early activation of innate im-
munity as the adaptive system is only involved much
later with infiltrating T cells. Also in a mouse model for
spinal cord injury, C1q is expressed on axons and oligo-
dendrocytes [45]. In Alzheimer disease, C1q causes acti-
vation of C3d, and via the complement pathway it can
activate microglia with a damaging effect on myelin and
axons [46]. Although the relationship between peroxi-
somes and innate immunity needs further investigation,
we speculate that metabolic abnormalities, likely related
to peroxisomal β-oxidation defects, initiate an early acti-
vation of the innate immune system, which together
with abnormalities in the formation and maintenance of
myelin creates an environment which is detrimental for
axons.
The absence of oxidative stress in young Nestin-Pex5−/−
mice is in contrast with recent findings in Abcd1 knockout
mice, a model for the AMN form of X-ALD. In these mice
oxidative damage to proteins was detected in spinal cord
but not in brain, preceding by several months axonal dam-
age in spinal cord. The crucial role of this oxidative stress
for the pathogenesis was further proven as anti-oxidative
therapy could prevent the degenerative phenotype.
Increased concentrations of the very long chain fatty acid,
C26:0 is thought to be the metabolic factor initiating oxida-
tive stress [47]. It remains unclear why this occurs in spinal
cord and not in brain with Abcd1 deficiency and likewise,
why C26:0 accumulation in Nestin-Pex5 knockout mice [4]
does not trigger an oxidative stress response. In fact, in
patients with ABCD1 deficiency, lipid peroxidation in
plasma was higher in the AMN phenotype than in cerebral
ALD and in asymptomatic patients [48]. On the other
hand, in PBD patients oxidative stress markers were not
increased in plasma or urine [49]. Taken together, the
causal relationship between oxidative stress and inflamma-
tory demyelination is currently unclear and we have no
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evidence that degeneration in the peroxisome deficient
brain is triggered or boosted by the development of oxida-
tive stress.
Conclusions
A lack of plasmalogens contributes to abnormalities in
the formation and stability of myelin but not to the un-
controlled pro-inflammatory response in the brain of
Nestin-Pex5−/− mice. This neurotoxic environment leads
to axonal damage and a chronic progression of neurode-
generation. It remains to be investigated whether the
neurodegenerative phenotype can be halted by blocking
the inflammatory response.
Additional files
Additional file 1: Table S1. Antibodies used for immunohistochemistry.
Additional file 2: Table S2. List of primers and probes used for real-
time PCR.
Additional file 3: Figure S1. Demyelination in different brain areas
visualized by deMBP. To visualize disintegration of myelin,
immunohistochemistry was performed with an antibody recognizing
degraded MBP (deMBP). DeMBP was present from 3 weeks on in the
cerebellum of Nestin-Pex5-/- mice (A–C) and also in the brain stem (D–F).
In addition, deMBP was seen in the cortex, although only at 3 weeks (G)
and virtually not at higher ages (H–I). The corpus callosum displays slight
deMBP immunoreactivity at 6 weeks (J) and 9 weeks (K), but much more
pronounced at 12 weeks (L). Scale bars: 100 μm.
Additional file 4: Figure S2. Pathology in the cerebellar peduncles.
(A–C) Triple immunolabeling of microglia (F4/80, green), degrading axons
(SMI32, red) and myelin (MBP, blue) was performed on brain sections of
6- to 9-week-old Nestin-Pex5-/- mice. At 6 and 9 weeks only sporadically a
microglial cell (B, arrow) and a SMI32 positive axon was observed (C,
arrows). MBP loss was not clearly seen at these ages with MBP. (D) 9-
week-old Nestin-Pex5-/- mice displayed deMBP immunoreactivity (green)
in the cerebellar peduncles, indicating demyelination. In addition,
damaged axons were observed in the same region with SMI32 (red,
arrows). (E–F) The cerebellar peduncles of 12-week-old Nestin-Pex5 mice
were also examined by triple staining for microglia (F4/80, green) or
activated microglial (MAC-3, green), axonal damage (SMI32, red) and
myelin (MBP, blue). At 12 weeks microgliosis (E) and microglia activation
(F) but also demyelination and axonal degeneration was more
pronounced than at earlier ages. (G–H) SMI31 immunoreactivity was
decreased in the knockout (H) compared with the control mice (G),
which represents axonal loss. Scale bars: 100 μm.
Additional file 5: Figure S3. Analysis of peroxisome inactivation in
tamoxifen induced CMV-Tx-Pex5-/- mice. Inactivation of PEX5p was
investigated by the visualization of catalase on brain sections of CMV-Tx-
Pex5 mice. Under normal circumstances catalase colocalizes with
peroxisomes, resulting in a punctuate staining pattern. PEX5p deficient
cells are not able to import catalase, resulting in ectopic localization of
catalase in the cytosol and consequently a green uniform staining of the
cell. Astrocytes (GFAP, red) and oligodendrocytes (CC-1, red) display the
cytosolic staining pattern of catalase (A and B, arrows) whereas neurons
(MAP-2, red) still contain the punctuate pattern (C, arrows). In microglial
cells (F4/80, red, arrows) neither a cytosolic nor a punctuate pattern can
be recognized, probably due to low levels of catalase (D). Scale bars: A–B:
50 μm; C–D: 20 μm.
Additional file 6: Figure S4. Brain pathology in mice with deletion of
functional peroxisomes in adulthood. (A) Motor performance of CMV-Tx-
Pex5-/- mice was tested by the use of an accelerating rotarod. At
3 months motor performance of knockout mice was indistinguishable
from the control littermates, but decreased significantly between 5 and
8 months. At least 4 animals were investigated per age and per
genotype. ** p < 0.01, *** p < 0.001 (student’s t-test). (B) (a–c) Labeling
of microglia (F4/80, green), degenerating axons (SMI32, red) and myelin
(MBP, blue) on brain sections of CMV-Tx-Pex5 mice. The cerebellum
displayed mild demyelination at 5 and 8 months (a–c) and several SMI32
positive axons at 5 months (b). (d–f) Axonal loss was detectable as a
decreased SMI31 immunoreactivity in 8-month-old CMV-Tx-Pex5-/-
compared to control mice. (f) Axonal swellings were also observed with
SMI31 (f, arrow). (g–i) F4/80 (green), SMI32 (red) and MBP (blue) triple
staining of corpus callosum. Microgliosis was detected in corpus callosum
of 5- and 8-month-old knockout mice, but there was no evidence for
demyelination nor axonal degeneration (g-i).
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